Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion type Assertion NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_head.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion description "[Furthermore, the properties of GPC5 make it an attractive target for therapeutic intervention in rhabdomyosarcomas and other tumors that amplify and/or overexpress the gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_provenance.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion evidence source_evidence_literature NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_provenance.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion SIO_000772 17210683 NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_provenance.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion wasDerivedFrom befree-20140225 NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_provenance.
- NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_assertion wasGeneratedBy ECO_0000203 NP401789.RAMHyBFb3EWuXLRHYJFJSddrgJAkAJQ9Bw51-aLkA6vMY130_provenance.